DE69229572D1 - Gliazellen-aktivierender Faktor und dessen Herstellung - Google Patents
Gliazellen-aktivierender Faktor und dessen HerstellungInfo
- Publication number
- DE69229572D1 DE69229572D1 DE69229572T DE69229572T DE69229572D1 DE 69229572 D1 DE69229572 D1 DE 69229572D1 DE 69229572 T DE69229572 T DE 69229572T DE 69229572 T DE69229572 T DE 69229572T DE 69229572 D1 DE69229572 D1 DE 69229572D1
- Authority
- DE
- Germany
- Prior art keywords
- activating factor
- glia activating
- glial cell
- glia
- production
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/4756—Neuregulins, i.e. p185erbB2 ligands, glial growth factor, heregulin, ARIA, neu differentiation factor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2086091 | 1991-02-14 | ||
JP22445491 | 1991-09-04 | ||
JP00339992A JP3385040B2 (ja) | 1991-02-14 | 1992-01-10 | グリア活性化因子およびその製造法 |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69229572D1 true DE69229572D1 (de) | 1999-08-19 |
DE69229572T2 DE69229572T2 (de) | 1999-11-11 |
Family
ID=27275805
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69229572T Expired - Lifetime DE69229572T2 (de) | 1991-02-14 | 1992-02-13 | Gliazellen-aktivierender Faktor und dessen Herstellung |
Country Status (6)
Country | Link |
---|---|
US (2) | US5512460A (de) |
EP (1) | EP0503297B1 (de) |
JP (1) | JP3385040B2 (de) |
AT (1) | ATE182174T1 (de) |
CA (1) | CA2061148C (de) |
DE (1) | DE69229572T2 (de) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5840836A (en) * | 1989-02-17 | 1998-11-24 | Bayer Corporation | Pancreatic islet cell antigens obtained by molecular cloning |
US6811989B1 (en) * | 1989-02-17 | 2004-11-02 | Bayer Corporation | Pancreatic islet cell antigens obtained by molecular cloning |
EP0585631A1 (de) * | 1992-08-05 | 1994-03-09 | Takeda Chemical Industries, Ltd. | Blutplättchen vermehrendes Agens |
EP0608546A3 (en) * | 1992-12-22 | 1995-09-27 | Takeda Chemical Industries Ltd | Glia activating factor (gaf), antibodies against it and their uses. |
CA2115522A1 (en) * | 1993-02-12 | 1994-08-13 | Takeda Pharmaceutical Company Limited | Hst-2 mutein, dna coding for the same and preparation thereof |
US5922572A (en) | 1994-01-25 | 1999-07-13 | Human Genome Sciences, Inc. | Polynucleotides encoding haemopoietic maturation factor |
ES2173289T3 (es) * | 1995-06-12 | 2002-10-16 | Yeda Res & Dev | Fgf9 como ligando especifico para fgfr3. |
US5731284A (en) * | 1995-09-28 | 1998-03-24 | Amgen Inc. | Method for treating Alzheimer's disease using glial line-derived neurotrophic factor (GDNF) protein product |
WO1998029547A1 (en) * | 1996-12-31 | 1998-07-09 | The Rockefeller University | Modulators of radial glia-astrocyte differentiation and transformation, and diagnostic and therapeutic uses thereof |
AU8999298A (en) * | 1997-09-08 | 1999-03-29 | Taisho Pharmaceutical Co., Ltd. | Protein having activity of activiting nerve cell functions |
US20010006939A1 (en) * | 1997-10-03 | 2001-07-05 | Ralph W. Niven | Secretory leukocyte protease inhibitor dry powder pharmaceutical compositions |
US7291483B2 (en) | 1999-07-27 | 2007-11-06 | Curagen Corporation | FGF-CX polynucleotide sequences and methods of producing same |
US7056885B1 (en) * | 1999-07-27 | 2006-06-06 | Curagen Corporation | Fibroblast growth factor and nucleic acids encoding same |
US20020058036A1 (en) * | 1999-07-27 | 2002-05-16 | Michael Jeffers | Novel fibroblast growth factor and nucleic acids encoding same |
IL139380A0 (en) * | 2000-10-31 | 2001-11-25 | Prochon Biotech Ltd | Active variants of fibroblast growth factor |
US6982250B2 (en) | 2000-11-06 | 2006-01-03 | Curagen Corporation | Methods of prevention and treatment of inflammatory bowel disease |
IL149562A0 (en) | 2002-05-09 | 2002-11-10 | Prochon Ltd | Fgf variants and methods for use thereof |
US7067123B2 (en) * | 2003-04-29 | 2006-06-27 | Musculoskeletal Transplant Foundation | Glue for cartilage repair |
US7901457B2 (en) | 2003-05-16 | 2011-03-08 | Musculoskeletal Transplant Foundation | Cartilage allograft plug |
US7837740B2 (en) | 2007-01-24 | 2010-11-23 | Musculoskeletal Transplant Foundation | Two piece cancellous construct for cartilage repair |
US7815926B2 (en) | 2005-07-11 | 2010-10-19 | Musculoskeletal Transplant Foundation | Implant for articular cartilage repair |
WO2007035778A2 (en) | 2005-09-19 | 2007-03-29 | Histogenics Corporation | Cell-support matrix and a method for preparation thereof |
CA2664921A1 (en) | 2006-09-28 | 2008-04-03 | Hepacore Ltd. | N-terminal fgf variants having increased receptor selectivity and uses thereof |
US8435551B2 (en) | 2007-03-06 | 2013-05-07 | Musculoskeletal Transplant Foundation | Cancellous construct with support ring for repair of osteochondral defects |
US8685107B2 (en) | 2007-07-03 | 2014-04-01 | Histogenics Corporation | Double-structured tissue implant and a method for preparation and use thereof |
US20090054984A1 (en) | 2007-08-20 | 2009-02-26 | Histogenics Corporation | Method For Use Of A Double-Structured Tissue Implant For Treatment Of Tissue Defects |
WO2009111069A1 (en) | 2008-03-05 | 2009-09-11 | Musculoskeletal Transplant Foundation | Cancellous constructs, cartilage particles and combinations of cancellous constructs and cartilage particles |
WO2012038953A2 (en) | 2010-09-21 | 2012-03-29 | Hepacore Ltd. | Fgf-18 truncated variants having increased receptor specificity and uses thereof |
WO2012140650A2 (en) | 2011-04-12 | 2012-10-18 | Hepacore Ltd. | Conjugates of carboxy polysaccharides with fibroblast growth factors and variants thereof |
US10077420B2 (en) | 2014-12-02 | 2018-09-18 | Histogenics Corporation | Cell and tissue culture container |
KR20210091195A (ko) | 2018-11-08 | 2021-07-21 | 인테그리컬쳐 인코포레이티드 | 동물 세포 증식 촉진제, 동물 세포 배양용 배지 및 동물 세포 배양 장치 |
-
1992
- 1992-01-10 JP JP00339992A patent/JP3385040B2/ja not_active Expired - Lifetime
- 1992-02-13 DE DE69229572T patent/DE69229572T2/de not_active Expired - Lifetime
- 1992-02-13 CA CA002061148A patent/CA2061148C/en not_active Expired - Fee Related
- 1992-02-13 EP EP92102385A patent/EP0503297B1/de not_active Expired - Lifetime
- 1992-02-13 AT AT92102385T patent/ATE182174T1/de active
-
1994
- 1994-11-17 US US08/340,820 patent/US5512460A/en not_active Expired - Lifetime
-
1996
- 1996-01-24 US US08/593,535 patent/US5622928A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JPH05301893A (ja) | 1993-11-16 |
EP0503297B1 (de) | 1999-07-14 |
ATE182174T1 (de) | 1999-07-15 |
CA2061148A1 (en) | 1992-08-15 |
US5622928A (en) | 1997-04-22 |
US5512460A (en) | 1996-04-30 |
JP3385040B2 (ja) | 2003-03-10 |
EP0503297A1 (de) | 1992-09-16 |
DE69229572T2 (de) | 1999-11-11 |
CA2061148C (en) | 2004-08-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69229572T2 (de) | Gliazellen-aktivierender Faktor und dessen Herstellung | |
CA2019363A1 (en) | Dna and use thereof | |
DE69019609T2 (de) | Proteine und deren Herstellung. | |
CA2127463A1 (en) | Biodegradable polymers for cell transplantation | |
CA2066618A1 (en) | Plasmids containing dna encoding the amino acid sequence of tcf-ii, transformed cells with the plasmids, and production method of biologically active substance using the transformed cells | |
EP0343783A3 (en) | Method for producing cells containing stably integrated foreign dna at a high copy number, the cells produced by this method, and the use of these cells to produce the polypeptides coded for by the foreign dna | |
GR3032790T3 (en) | Materials and methods for hypersecretion of amino acids | |
EP0546110A4 (en) | New insulin-like growth factor binding protein igfbp-5 | |
DK1396542T3 (da) | P-selectin ligand protein | |
AU4683489A (en) | Tgf-beta 1/beta 2: a novel chimeric transforming growth factor-beta | |
HK34896A (en) | Novel polypeptide and production thereof | |
ATE70302T1 (de) | Verfahren zur expression von alpha-1-antitrypsin in bakterien und dessen verwendung in therapeutischen zusammensetzungen sowie vektoren und bakterien fuer ein solches verfahren und deren herstellung. | |
EP0546074A4 (en) | Genetic material encoding igfbp-5 | |
EP0649900A3 (de) | Verfahren zur Herstellung von Proteinen. | |
GR3020790T3 (en) | Achromobacter protease I gene and gene product thereof | |
CA2052396A1 (en) | Synthetic gene coding for human parathyroid hormone | |
RU96121465A (ru) | Биосинтез рибофлавина в грибах | |
ATE84065T1 (de) | Expressionsvektor fuer menschlichen insulinaehnlichen wachstumsfaktor-i. | |
CA2080008A1 (en) | Water-soluble mutein of fibroblast growth factor (fgf) receptor | |
AU7880987A (en) | Human B-cell differentiation factor and process of producing said factor | |
ATE346941T1 (de) | Protein-disulfidisomerase-gen eines methylotrophen hefestammes | |
Yin et al. | Fermentation process. | |
Shiio et al. | Process for the production of L-threonine by fermentation. | |
CA2126090A1 (en) | Process for preparing neuraminidase | |
EP0477791A3 (en) | Polypeptide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8327 | Change in the person/name/address of the patent owner |
Owner name: TAKEDA PHARMACEUTICAL CO. LTD., OSAKA, JP |